Andrew Gaudin: Pharmacy Guild CEO on the reclassification of CBD products

Published: Oct. 19, 2023, 7:10 p.m.

A step towards increasing the availability of CBD products.\xa0

CBD is a compound found in marijuana but has little to no psychoactive effects.\xa0

Medsafe has reclassified CBD from prescription only to a restricted medicine, meaning low-dose CBD medicines can be sold by pharmacists.\xa0

But Pharmacy Guild Chief Executive Andrew Gaudin told Mike Hosking that there are currently no low-dose products approved here.\xa0

He says this is the encouragement to manufacturers to start the process of developing products, which they'll then have to demonstrate the benefits of to get them approved.\xa0

LISTEN ABOVE\xa0

See omnystudio.com/listener for privacy information.